Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Lack of association between KRAS mutations and 18F-FDG PET/CT in Caucasian metastatic colorectal cancer patients.

Krikelis D, Skoura E, Kotoula V, Rondogianni P, Pianou N, Samartzis A, Xanthakis I, Fountzilas G, Datseris IE.

Anticancer Res. 2014 May;34(5):2571-9.

PMID:
24778079
[PubMed - indexed for MEDLINE]
2.

A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).

Pentheroudakis G, Kotoula V, Fountzilas E, Kouvatseas G, Basdanis G, Xanthakis I, Makatsoris T, Charalambous E, Papamichael D, Samantas E, Papakostas P, Bafaloukos D, Razis E, Christodoulou C, Varthalitis I, Pavlidis N, Fountzilas G.

BMC Cancer. 2014 Feb 20;14:111. doi: 10.1186/1471-2407-14-111.

PMID:
24555920
[PubMed - in process]
Free PMC Article
3.

Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.

Briasoulis E, Aravantinos G, Kouvatseas G, Pappas P, Biziota E, Sainis I, Makatsoris T, Varthalitis I, Xanthakis I, Vassias A, Klouvas G, Boukovinas I, Fountzilas G, Syrigos KN, Kalofonos H, Samantas E.

BMC Cancer. 2013 May 29;13(1):263. [Epub ahead of print]

PMID:
23718900
[PubMed - as supplied by publisher]
Free PMC Article
4.

Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.

Fountzilas G, Dafni U, Bobos M, Kotoula V, Batistatou A, Xanthakis I, Papadimitriou C, Kostopoulos I, Koletsa T, Tsolaki E, Televantou D, Timotheadou E, Koutras A, Klouvas G, Samantas E, Pisanidis N, Karanikiotis C, Sfakianaki I, Pavlidis N, Gogas H, Linardou H, Kalogeras KT, Pectasides D, Dimopoulos MA.

BMC Cancer. 2013 Mar 28;13:163. doi: 10.1186/1471-2407-13-163.

PMID:
23537287
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.

Pentheroudakis G, Kotoula V, De Roock W, Kouvatseas G, Papakostas P, Makatsoris T, Papamichael D, Xanthakis I, Sgouros J, Televantou D, Kafiri G, Tsamandas AC, Razis E, Galani E, Bafaloukos D, Efstratiou I, Bompolaki I, Pectasides D, Pavlidis N, Tejpar S, Fountzilas G.

BMC Cancer. 2013 Feb 2;13:49. doi: 10.1186/1471-2407-13-49.

PMID:
23374602
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03).

Bamias A, Dafni U, Karadimou A, Timotheadou E, Aravantinos G, Psyrri A, Xanthakis I, Tsiatas M, Koutoulidis V, Constantinidis C, Hatzimouratidis C, Samantas E, Visvikis A, Chrisophos M, Stravodimos K, Deliveliotis C, Eleftheraki A, Pectasides D, Fountzilas G, Dimopoulos MA.

Ann Oncol. 2013 Apr;24(4):1011-7. doi: 10.1093/annonc/mds583. Epub 2012 Nov 7.

PMID:
23136231
[PubMed - indexed for MEDLINE]
Free Article
7.

Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab.

Fountzilas G, Christodoulou C, Bobos M, Kotoula V, Eleftheraki AG, Xanthakis I, Batistatou A, Pentheroudakis G, Xiros N, Papaspirou I, Koumarianou A, Papakostas P, Bafaloukos D, Skarlos DV, Kalogeras KT.

J Transl Med. 2012 Oct 23;10:212. doi: 10.1186/1479-5876-10-212.

PMID:
23092535
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis.

Pectasides D, Papaxoinis G, Kalogeras KT, Eleftheraki AG, Xanthakis I, Makatsoris T, Samantas E, Varthalitis I, Papakostas P, Nikitas N, Papandreou CN, Pentheroudakis G, Timotheadou E, Koutras A, Sgouros J, Bafaloukos D, Klouvas G, Economopoulos T, Syrigos KN, Fountzilas G.

BMC Cancer. 2012 Jun 29;12:271. doi: 10.1186/1471-2407-12-271.

PMID:
22748098
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer.

Kalofonos HP, Papakostas P, Makatsoris T, Papamichael D, Vourli G, Xanthakis I, Aravantinos G, Papadimitriou C, Pentheroudakis G, Varthalitis I, Samelis G, Syrigos KN, Xiros N, Stavropoulos M, Kosmidis P, Christodoulou C, Linardou H, Skondra M, Pectasides D, Economopoulos T, Fountzilas G.

Anticancer Res. 2010 Oct;30(10):4325-33.

PMID:
21036759
[PubMed - indexed for MEDLINE]
10.

Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model.

Bamias A, Karadimou A, Lampaki S, Lainakis G, Malettou L, Timotheadou E, Papazisis K, Andreadis C, Kontovinis L, Anastasiou I, Stravodimos K, Xanthakis I, Skolarikos A, Christodoulou C, Syrigos K, Papandreou C, Razi E, Dafni U, Fountzilas G, Dimopoulos MA.

BMC Cancer. 2010 Feb 18;10:45. doi: 10.1186/1471-2407-10-45.

PMID:
20163744
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Pegfilgrastim administered on the same day with dose-dense adjuvant chemotherapy for breast cancer is associated with a higher incidence of febrile neutropenia as compared to conventional growth factor support: matched case-control study of the Hellenic Cooperative Oncology Group.

Skarlos DV, Timotheadou E, Galani E, Samantas E, Grimani I, Lianos E, Aravantinos G, Xanthakis I, Pentheroudakis G, Pectasides D, Fountzilas G.

Oncology. 2009;77(2):107-12. doi: 10.1159/000229504. Epub 2009 Jul 21.

PMID:
19622901
[PubMed - indexed for MEDLINE]
12.

Solitary large hepatic metastasis in an elderly patient with anaplastic thyroid carcinoma: a case report.

Adamidou A, Kotsaftis P, Vlachou M, Haritanti A, Xanthakis I, Zantidis A, Ntaios G.

Cases J. 2009 Jan 12;2(1):41. doi: 10.1186/1757-1626-2-41.

PMID:
19138396
[PubMed]
Free PMC Article
13.

Clear cell ovarian carcinoma following polymyositis diagnosis: a case report and review of the literature.

Kalogiannidis I, Papanikolaou A, Xanthakis I, Makedos A, Prapas N.

Hippokratia. 2008 Jul;12(3):181-5.

PMID:
18923746
[PubMed]
Free PMC Article
14.

Weekly docetaxel regimens and radiation pneumonitis.

Mauri D, Tzachanis D, Tsekoura P, Xanthakis I, Tsali L, Roumbkou S, Fountzilas G.

J Support Oncol. 2008 Jul-Aug;6(6):265-6. No abstract available.

PMID:
18724534
[PubMed - indexed for MEDLINE]
15.

Potential value of PTEN in predicting cetuximab response in colorectal cancer: an exploratory study.

Razis E, Briasoulis E, Vrettou E, Skarlos DV, Papamichael D, Kostopoulos I, Samantas E, Xanthakis I, Bobos M, Galanidi E, Bai M, Gikonti I, Koukouma A, Kafiri G, Papakostas P, Kalogeras KT, Kosmidis P, Fountzilas G.

BMC Cancer. 2008 Aug 13;8:234. doi: 10.1186/1471-2407-8-234.

PMID:
18700047
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: a Hellenic Cooperative Oncology Group (HeCOG) phase II study.

Makatsoris T, Papakostas P, Kalofonos HP, Xanthakis I, Tsavdaridis D, Aravantinos G, Gogas H, Klouvas G, Kosmidis P, Pectasides D, Fountzilas G.

Med Oncol. 2007;24(3):301-7.

PMID:
17873305
[PubMed - indexed for MEDLINE]
17.

Prognostic factors in patients with colorectal cancer receiving adjuvant chemotherapy or chemoradiotherapy: a pooled analysis of two randomized studies.

Bamias A, Basdanis G, Xanthakis I, Pavlidis N, Fountzilas G.

Int J Gastrointest Cancer. 2005;36(1):29-38.

PMID:
16227633
[PubMed - indexed for MEDLINE]
18.

Regression of inflammatory myofibroblastic tumor of the gastrointestinal tract under infliximab treatment.

Germanidis G, Xanthakis I, Tsitouridis I, Zaramboukas T, Kiskinis D, Konstantaras C, Miliaras S, Sirakos T, Pagkalos E.

Dig Dis Sci. 2005 Feb;50(2):262-5. No abstract available.

PMID:
15745083
[PubMed - indexed for MEDLINE]
19.

Relative bioavailability study of two nifedipine tablet formulations in healthy male volunteers.

Niopas I, Daftsios AC, Xanthakis I, Nikolaidis N.

Int J Clin Pharmacol Ther. 2000 Jun;38(6):309-14.

PMID:
10890580
[PubMed - indexed for MEDLINE]
20.

Bioequivalence of two tablet formulations of atenolol after single oral administration in healthy volunteers.

Niopas I, Daftsios AC, Xanthakis I, Nikolaidis N, Njau SN.

Arzneimittelforschung. 2000 Mar;50(3):243-7.

PMID:
10758775
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk